1-4 of 4
Ali Bazarbachi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study

Ali Bazarbachi, Myriam Labopin, Nour Moukalled, Nicolaus Kröger, Christina Rautenberg, Johannes Schetelig, Jürgen Finke, Igor Wolfgang Blau, Didier Blaise, Matthias Stelljes, Matthias Eder, Uwe Platzbecker, Peter Dreger, Wolfgang Bethge, Johanna Tischer, David Burns, Henrik Sengeloev, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (9): 1778–1787.
https://doi.org/10.1158/1078-0432.CCR-23-3673
Published: 01 May 2024
View article titled, Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study
Open the PDF for Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study in another window
Includes: Supplementary data
Journal Articles

Improved Posttransplant Outcomes in Recent Years for AML Patients with FLT3-ITD and Wild-type NPM1: A Report from the EBMT Acute Leukemia Working Party

Ali Bazarbachi, Myriam Labopin, Tobias Gedde-Dahl, Peter Remenyi, Edouard Forcade, Nicolaus Kröger, Gerard Socié, Charles Craddock, Jean Henri Bourhis, Jurjen Versluis, Ibrahim Yakoub-Agha, Urpu Salmenniemi, Jean El-Cheikh, Gesine Bug, Jordi Esteve, Arnon Nagler, Fabio Ciceri, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (21): 4441–4448.
https://doi.org/10.1158/1078-0432.CCR-23-0954
Published: 01 November 2023
View article titled, Improved Posttransplant Outcomes in Recent Years for AML Patients with <em>FLT3</em>-ITD and Wild-type <em>NPM1</em>: A Report from the EBMT Acute Leukemia Working Party
Open the PDF for Improved Posttransplant Outcomes in Recent Years for AML Patients with <em>FLT3</em>-ITD and Wild-type <em>NPM1</em>: A Report from the EBMT Acute Leukemia Working Party in another window
Journal Articles

20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation

Ali Bazarbachi, Myriam Labopin, Mahmoud Aljurf, Riitta Niittyvuopio, Marie Balsat, Didier Blaise, Ibrahim Yakoub-Agha, Anna Grassi, Hans Christian Reinhardt, Stig Lenhoff, Pavel Jindra, Jakob Passweg, Iman Abou Dalle, Michael Stadler, Bruno Lioure, Patrice Ceballos, Eolia Brissot, Sebastian Giebel, Arnon Nagler, Christoph Schmid, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 1004–1012.
https://doi.org/10.1158/1078-0432.CCR-21-2675
Published: 03 March 2022
View article titled, 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation
Open the PDF for 20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation in another window
Journal Articles

Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years

Ali Bazarbachi, Christoph Schmid, Myriam Labopin, Dietrich Beelen, Igor Wolfgang Blau, Victoria Potter, Riitta Niittyvuopio, Gerard Socié, Didier Blaise, Jaime Sanz, Fabio Ciceri, Iman Abou Dalle, Alexandros Spyridonidis, Gesine Bug, Jordi Esteve, Bipin N. Savani, Arnon Nagler, Mohamad Mohty
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (24): 6475–6482.
https://doi.org/10.1158/1078-0432.CCR-20-3134
Published: 15 December 2020
View article titled, Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years
Open the PDF for Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years in another window
Includes: Supplementary data